News
QDEL
39.12
+2.25%
0.86
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
Barchart · 14h ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
Barchart · 1d ago
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
Barchart · 1d ago
QuidelOrtho Enters Oversold Territory (QDEL)
NASDAQ · 2d ago
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
Barchart · 2d ago
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
Barchart · 2d ago
Press Release: QuidelOrtho To Report First Quarter 2024 Financial Results
Dow Jones · 2d ago
QuidelOrtho To Report First Quarter 2024 Financial Results
Barchart · 2d ago
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP
TipRanks · 3d ago
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
Law Offices of Howard G. Smith announces a class action lawsuit has been filed on behalf of investors who purchased QuidelOrtho Corporation common stock between February 18, 2022 and April 1, 2024. Investors have until June 11, 2024 to file a lead plaintiff motion. The lawsuit alleges that Quidel ortho made false and/or misleading statements.
Barchart · 3d ago
Benjamin Graham Detailed Fundamental Analysis - QDEL
NASDAQ · 4d ago
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
Rosen Law Firm announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18, 2022 and April 1, 2024. If you purchased common stock during the Class Period you may be entitled to compensation. The lawsuit claims defendants made false and/or misleading statements. A class action has already been filed.
Barchart · 4d ago
Weekly Report: what happened at QDEL last week (0408-0412)?
Weekly Report · 4d ago
QuidelOrtho: Attractive Valuation Despite Weak Performance
QuidelOrtho Corporation's revenue growth in 2023 was below targets. The company's profitability has been impacted by higher depreciation and non-operating expenses. However, improvements in gross margins and reduced expenses are expected in 2024. The Labs segment outperformed expectations and the Transfusion Medicine, Point of Care, and Molecular Diagnostics segments underperformed.
Seeking Alpha · 6d ago
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Corporation and Certain Executives
QuidelOrtho Corporation, formerly known as Quidel Corporation, filed a securities class action lawsuit on April 12, 2024. The company's stock dropped 32 percent after the company announced it had withdrawn its FDA approval for the Savanna RVP4 Test. Quidel ortho provides tests for the detection and diagnosis of respiratory diseases.
Barchart · 6d ago
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Company and Certain Executives
QuidelOrtho Corporation, formerly known as Quidel Corporation, filed a securities class action lawsuit on April 12, 2024. The company's stock dropped 32 percent after the company announced it had withdrawn its FDA approval for the Savanna RVP4 Test. Quidel ortho provides tests for the detection and diagnosis of respiratory diseases.
Barchart · 04/12 17:00
QuidelOrtho's (QDEL) New Test to Offer Enhanced Opioid Testing
NASDAQ · 04/12 15:47
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
Rosen Law Firm continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation. The company may have issued materially misleading business information to the investing public. Rosen Law Firm is a global investor rights law firm. The company is called Quidel ortho.
Barchart · 04/10 15:08
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
TipRanks · 04/09 01:46
We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt
QuidelOrtho Corporation (NASDAQ:QDEL) has US$2.42b of debt on its balance sheet. The company uses debt to fund its operations. Its debt to EBITDA ratio is higher than average for a medical equipment company. Quidel ortho saw its EBIT drop 72% over the last 12 months. But the company's free cash flow suggests it is in a good position to pay off its debt.
Simply Wall St · 04/08 11:37
More
Webull provides a variety of real-time QDEL stock news. You can receive the latest news about Quidel through multiple platforms. This information may help you make smarter investment decisions.
About QDEL
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.